Skip to main content Skip to section navigation Skip to footer
CohBar, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Programs & Pipelines
    • Overview
    • Our Approach
    • CB5138-3
    • CB4211
    • CB5064 Analogs
    • Posters & White Papers
  • Patient Resources
    • Overview
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Partners
  • Careers
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
May 16, 2022 4:01pm EDT

CohBar Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress

May 12, 2022 9:00am EDT

CohBar Announces Extension of Nasdaq Compliance Period and Summarizes 2022 Annual Meeting Proposal

May 02, 2022 9:00am EDT

CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022

Mar 29, 2022 4:01pm EDT

CohBar Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

Mar 15, 2022 9:00am EDT

CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022

Jan 03, 2022 9:00am EST

CohBar to Present at H.C. Wainwright BIOCONNECT Conference

Dec 17, 2021 9:00am EST

CohBar Announces Changes to its Board of Directors and R&D Leadership

Nov 29, 2021 9:00am EST

CohBar’s CEO to Participate in Upcoming BIO Webinar

Nov 15, 2021 4:02pm EST

CohBar Reports Third Quarter 2021 Financial Results and Provides Business Update

Nov 01, 2021 9:00am EDT

CohBar to Announce 2021 Third Quarter Financial Results and Provide Business Update on November 15, 2021

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …17
  • arrow_forward
©2022 CohBar, Inc. All Rights Reserved.
Privacy Policy Sitemap Terms of Use